Loading company…
Neurophet develops AI tools for brain imaging analysis and the diagnosis and management of brain diseases.
Founded in 2016 in Seoul, South Korea, Neurophet develops AI-driven brain imaging tools for medical professionals and researchers. Its products include Neurophet AQUA for analyzing conditions such as Multiple Sclerosis and Alzheimer's disease, along with neuromodulation technology. In February 2024, it received KRW 1 billion in venture funding from Samjin Pharmaceutical for research collaboration and product commercialization.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in